Atlas Trials

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Clinical trial NCT00952731 · COMPLETED

Trial details

NCT number
NCT00952731
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Start date
2009-12-01
Primary completion
2011-09-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.